Back to Bills
HOUSE-BILL 2636119th Congress

HOUSE-BILL 2636: H.R.2636 - Making Insulin Affordable for All Children Act

Introduced: April 3, 2025
Status: Referred to Committee
R.for.R

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 2636 aims to enhance access to insulin products for individuals aged 26 years or younger by mandating that group health plans and health insurance issuers provide coverage without deductibles and limit cost-sharing to a maximum of $35 or 25% of the negotiated price per 30-day supply. The legislation addresses major themes of health care access and equal protection under the law, emphasizing the need for affordable medications for a vulnerable population. Key provisions include the requirement for health plans to cover at least one dosage form of each type of insulin and the implementation of these provisions through sub-regulatory guidance, which may raise concerns about clarity and enforceability. The bill's potential impacts include improved health outcomes and reduced disparities in health care access, while also raising constitutional questions regarding federal regulation of private health plans and the balance of state versus federal powers.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill's provisions may enhance access to essential medications for a specific demographic, but they also risk infringing upon the equal protection rights of individuals outside that demographic. This creates a tension between promoting public health and ensuring fair treatment under the law.

Key Individual Rights

  • Equal Protection under the law
  • Access to necessary health care

Constitutional Provisions

  • Equal Protection Clause (14th Amendment)
  • Commerce Clause (Article I, Section 8)

Potential Constitutional Challenges

  • Age discrimination claims could arise, questioning the fairness of limiting benefits to a specific age group.
  • Federalism issues may be raised regarding the imposition of federal standards on state-regulated health plans.

Summary

While HOUSE-BILL 2636 aims to improve access to insulin for young individuals, it raises significant constitutional questions regarding equal protection and potential age discrimination. The bill's focus on a specific age group may lead to legal challenges that could impact its implementation and the broader discourse on health care rights.

Constitutional Analysis

R.for.R

This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 2636 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

April 3, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat